Pasignajen Victoriosa MD is categorized under Geriatric Physicians and Doctors in Staten Island, NY and active since 1989.
Pasignajen Victoriosa MD was established in 1989, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Geriatric Physicians and Doctors business, which does work in the B2C market, and is classified as a Geriatric Physicians and Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Victoriosa Pasignajen at the company’s single location by writing to 491 Bard Avenue, Staten Island, New York NY 10310 or by phoning (718) 442-1312. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pasignajen Victoriosa MD |
Contact Person: | Victoriosa Pasignajen |
Address: | 491 Bard Avenue, Staten Island, New York 10310 |
Phone Number: | (718) 442-1312 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1989 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Geriatric Physicians and Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Pasignajen Victoriosa MD was started in 1989 to provide professional Geriatric Physicians and Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Victoriosa Pasignajen for inquiries that concern Pasignajen Victoriosa MD by calling the company number (718) 442-1312, as your correspondence is most welcome. Additionally, the physical location of the single location of Pasignajen Victoriosa MD can be found at the coordinates 40.630894,-74.105604 as well as the street address 491 Bard Avenue in Staten Island, New York 10310.
For its online presence, you may visit Pasignajen Victoriosa MD’s website at and engage with its social media outlets through on Twitter and on Facebook.